Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health Closes Down 7.26%, Largest Percent Decrease Since Nov 2016 -- Data Talk

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 10:50pm CET

CVS Health closed at $73.19, down $5.73 or 7.26%

-- Lowest close since Aug. 15, 2018, when it closed at $71.64

-- Largest percent decrease since Nov. 8, 2016, when it fell 11.82%

-- On Wednesday, Justice Department antitrust enforcers cleared CVS Health's acquisition of Aetna after the companies took steps to ease regulators' concerns, moving the nearly $70 billion deal a major step closer to completion

-- On Wednesday, CVS Health said Eva Boratto will become chief financial officer following the closing of its acquisition of Aetna Inc.

-- Worst three-day stretch since the three days ending May 3, 2018, when it fell 10.83%

-- Down 7.02% month-to-date

-- Down 35.49% from its all-time closing high of $113.45 on July 29, 2015

-- Down 0.80% from 52 weeks ago (Oct. 12, 2017), when it closed at $73.78

-- Down 12.48% from its 52 week closing high of $83.63 on Jan. 29, 2018

-- Traded as low as $72.60; lowest intraday level since Aug. 16, 2018, when it hit $72.00

-- Down 8.01% at today's intraday low; largest intraday percent decrease since June 28, 2018, when it fell as much as 10.01%

-- Today's preliminary volume is 17.0 million shares; highest since Aug. 8, 2018, when 18.5 million shares were traded

-- Second-worst performer in the S&P 500 today

Source: Dow Jones Market Data, FactSet

Stocks mentioned in the article
ChangeLast1st jan.
AETNA 0.33% 212.7 Delayed Quote.17.91%
CVS HEALTH CORPORATION -2.03% 71.88 Delayed Quote.1.20%
DJ INDUSTRIAL -2.02% 24100.51 Delayed Quote.-2.50%
NASDAQ 100 -2.56% 6594.9632 Delayed Quote.5.81%
NASDAQ COMP. -2.26% 6910.6648 Delayed Quote.2.42%
S&P 500 -1.91% 2599.95 Delayed Quote.-2.76%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
01:31aCVS HEALTH : defends settlement that allowed Aetna merger as judge assesses
RE
12/14CVS HEALTH : Sharecare launches Sharecare Rx to help make medications more affor..
AQ
12/13CVS and Delta fall while Aflac and General Electric jump
AQ
12/12CVS HEALTH : Public and Private Organizations Convene to Improve Health of Hispa..
PR
12/11CVS HEALTH : Statement on PA Auditor General's Report on PBMs
PU
12/07CVS HEALTH : Walgreens debuts expanded home delivery service
AQ
12/06CVS HEALTH : Walgreens expands prescription delivery program nationwide
AQ
12/05CVS HEALTH : Introduces New Approach to Pricing of Pharmacy Benefit Management S..
PR
12/04CVS HEALTH : U.S. judge concerned over government nod for CVS-Aetna deal
RE
12/04CVS PHARMACY : Completes Rollout of Time Delay Safes in All Kentucky Pharmacy Lo..
PR
More news
Financials ($)
Sales 2018 195 B
EBIT 2018 10 612 M
Net income 2018 1 927 M
Debt 2018 66 879 M
Yield 2018 2,77%
P/E ratio 2018 38,85
P/E ratio 2019 10,84
EV / Sales 2018 0,82x
EV / Sales 2019 0,62x
Capitalization 92 955 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 93,0 $
Spread / Average Target 29%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors